MDCX Earnings Date: Nov 13, 2026 (Estimated) — Medicus Pharma Ltd. Common Stock
NASDAQ · Healthcare · Drug Manufacturers - General
Updated
When is MDCX's next earnings date?
Medicus Pharma Ltd. Common Stock (MDCX) is expected to report Q3 2026 earnings on Friday, November 13, 2026 at 5:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$6.68.
How did MDCX do in its last earnings report?
In its most recent report on Aug 12, 2026 (Q2 2026), Medicus Pharma Ltd. Common Stock posted EPS of -$10.50 versus the -$318.75 estimate, a beat of 31.3%. Revenue was $0. The stock's 1-day post-earnings move was +6.9%.
How much does MDCX stock move after earnings?
MDCX beat EPS estimates in 1 of its last 5 reported quarters. Over the last 5 reports the stock moved an average of 7.9% (up or down) in the day after earnings.
About Medicus Pharma Ltd. Common Stock
Medicus Pharma Ltd., a biotechnology and life sciences enterprise, is dedicated to expediting the progression of innovative and groundbreaking medical treatments through their clinical development phases. A primary focus for the company is the creation of non-surgical solutions specifically targeting dermatological malignancies.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-12 | Q2 2026 | -318.75 | -10.50 | -31.25% | $0 | ✅ Beat | +6.88% | -20.11% | -50.91% |
| 2026-05-14 | Q1 2026 | -10.50 | -15.50 | -47.62% | $0 | ❌ Miss | -10.68% | -15.13% | -5.04% |
| 2026-03-25 | Q4 2025 | -17.00 | -41.50 | -144.12% | $0 | ❌ Miss | -5.71% | -14.96% | -36.24% |
| 2025-11-14 | Q3 2025 | -19.00 | -56.00 | -194.74% | $0 | ❌ Miss | -2.65% | -9.73% | -19.03% |
| 2025-08-11 | Q2 2025 | -19.50 | -21.50 | -10.26% | $0 | ❌ Miss | +13.71% | +1.52% | +3.05% |
Showing last 5 quarters.